Source: International Congress 2017 – Scientific year in review
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Johnston (London, United Kingdom). From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections. International Congress 2017 – Scientific year in review

Member's Comments

No comment yet.

Related content which might interest you: From the bedside: upcoming new clinical strategies Source: International Congress 2016 – Scientific Year in Review 2016 Year: 2016 The challenges of severe pneumonia: new pathogens, new drugs and new formulations Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019 Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19 Source: Eur Respir J, 55 (6) 2000858; 10.1183/13993003.00858-2020 Year: 2020 Update on management of new emerging acute respiratory viral infectious diseases Source: International Congress 2018 – Chinese Programme 2018: Part I Year: 2018 Improved diagnostics and diagnostic approaches: The role in the fight to emerging infectious diseases (EID) and antimicrobial resistance (AMR) Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021 Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies Source: International Congress 2019 – Scientific Year in review Year: 2019 Widespread use of face masks and respiratory viral infections: the SARS-CoV-2 pandemic lesson Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Antibiotic resistance in respiratory infections: challenges and actions for the upcoming decade Source: Virtual Congress 2021 – Respiratory infections Year: 2021 The new WHO air quality guidelines: policy and clinical implications for children with respiratory diseases Source: Virtual Congress 2021 – The environment and climate change effects on lung health across the lifecourse Year: 2021 Barriers to new drug development in respiratory disease Source: Eur Respir J 2016; 47: 356-357 Year: 2016 Barriers to new drug development in respiratory disease Source: Eur Respir J 2015; 45: 1197-1207 Year: 2015 Impact of continuous medical education (CME) training on improving diagnostic and therapeutic approach to respiratory infections: results of the MATerA project Source: Eur Respir J 2004; 24: Suppl. 48, 86s Year: 2004 Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies? Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021 Year: 2022 Economic aspects of enhanced testing strategies for respiratory diseases Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021 HAP/VAP : new guidelines, new approaches Source: International Congress 2018 – Chinese Programme 2018: Part II Year: 2018